E-Paper
Does diabetes medication quality matter? Endocrinologist Dr M.V. Rama Mohan reveals the truth behind GLP-1 therapies
Why is quality crucial in GLP-1 therapies for diabetes? Highlight the importance of science, manufacturing, and clinical evidence for optimal patient outcomes.
Prefer HTon Google
Research-Backed Choices
Every product we recommend is chosen through a combination of Primary Research and Secondary Research.
The treatment landscape for type 2 diabetes has evolved significantly in recent years. As care has expanded beyond blood sugar control to include the reduction of cardiovascular and kidney complications, glucagon-like peptide-1 (GLP-1) receptor agonists have become an important part of diabetes management. Alongside innovation and expanding access, quality is another factor increasingly shaping clinical conversations.
For complex therapies such as GLP-1 receptor agonists, quality goes far beyond the active ingredient. "It is built into every stage of a medicine's development, from the science behind the molecule and the manufacturing process to the strength of the clinical evidence supporting its use", Dr M.V.Rama Mohan, Consultant Endocrinologist & Diabetologist, Diabetes & Endocrine Clinic, and Apollo Specialty Hospitals, Pinakini Nagar, Nellore, AP, tells Health Shots. These elements are particularly important in the management of type 2 diabetes, a chronic condition where patients often remain on therapy for years.
Does GLP-1 use mRNA technology?
The rise of diabetes in India highlights why this discussion matters. More than 100 million adults in the country are currently living with diabetes, and this number is expected to exceed 150 million by 2050. People in India also tend to develop type 2 diabetes nearly a decade earlier than those in many Western countries, increasing their lifetime risk of complications such as cardiovascular disease and chronic kidney disease. Despite advances in treatment, only three in ten people with diabetes achieve recommended blood sugar targets, underscoring the need for therapies that are both effective and reliable over the long term.
Some GLP-1 therapies have been developed using recombinant DNA (rDNA) technology, a major scientific advance in the treatment of type 2 diabetes. Along with this technology, carefully controlled manufacturing processes help ensure that these medicines are produced with consistent quality, stability, and reliability.
Why are peptides so important?
This is especially important because peptide-based medicines are more complex than many conventional medicines. Even small changes during manufacturing can affect a medicine's structure, stability, or how it works in the body. That is why strict quality standards and robust manufacturing processes are essential to ensure every batch delivers the same level of quality and performance.
Quality is also reflected in the strength of the clinical evidence behind a therapy. Medicines studied in large clinical trials, involving diverse patient populations and supported by long-term real-world experience, give healthcare professionals greater confidence in their safety, effectiveness, and long-term use. This is particularly important in type 2 diabetes, where patients often require treatment for many years.
Does GLP-1 help regulate blood sugar?
The role of GLP-1 therapies has also expanded beyond blood sugar control. Research is also exploring their potential in other metabolic conditions. As these therapies become an increasingly important part of diabetes care, maintaining consistent quality across their development, manufacturing, and clinical evaluation becomes even more important.
At the same time, wider access should go hand in hand with responsible use. Appropriate patient selection, physician supervision, and patient education are essential to ensure these therapies are used safely and effectively. As more treatment options become available, healthcare professionals are looking beyond the molecule itself and placing greater emphasis on the science, manufacturing standards, and clinical evidence that support a medicine's quality.
Ultimately, quality is becoming a defining factor in GLP-1 therapies. It is not determined by a single attribute, but by the combination of sound science, robust manufacturing, and strong clinical evidence. Together, these elements help ensure consistent performance and support better long-term outcomes for people living with type 2 diabetes.
(Disclaimer: At Hindustan Times, we help you stay up to date with the latest trends and products. Hindustan Times has an affiliate partnership, so we may get a part of the revenue when you make a purchase. We shall not be liable for any claim under applicable laws, including but not limited to the Consumer Protection Act, 2019, with respect to the products. The products listed in this article are in no particular order of priority. They were provided to HT Shop Now by the brand for testing and evaluation. Our opinions remain independent and based on our personal experience with the items. Please patch test the products before use.)
Catch your daily dose of Fashion, Taylor Swift, Health, Festivals, Travel, Relationship, Recipe and all the other Latest Lifestyle News on Hindustan Times Website and APPs.
